Buscar

Barra de búsqueda
01/04/2025 Real-world Efficacy of Brodalumab in Patients with moderate to severe Plaque Psoriasis, in Patients with BMI>30 and BMI=30, BROACTIVE: 2-year Results
Escalas, J, Armesto, S, Abalde, T, Blanco, IR, Blanco, MR, Herrera-Acosta, E, Puig, L, Morales, AM, Ferrán-Farrés, M, Auhage, E, Ribera, M. Real-world Efficacy of Brodalumab in Patients with moderate to severe Plaque Psoriasis, in Patients with BMI>30 and BMI=30, BROACTIVE: 2-year Results. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).
01/04/2025 Absolute EASI response achieved by lebrikizumab over 16 weeks in patients with moderate-to-severe atopic dermatitis
Thaçi, D, Puig, L, Papp, K, Gold, LS, Fernández-Peñas, P, Huang, YH, Dossenbach, M, Falques, M, Agell, H, Schönherr, F, Vestergaard, C. Absolute EASI response achieved by lebrikizumab over 16 weeks in patients with moderate-to-severe atopic dermatitis. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).
01/01/2025 EFFECTIVENESS OF 12-MONTHS TRALOKINUMAB TREATMENT IN 124 ADULTS WITH ATOPIC DERMATITIS WITH GENITAL INVOLVEMENT: FINAL REAL-WORLD DATA FROM THE PROSPECTIVE, NON-INTERVENTIONAL, INTERNATIONAL, SINGLE-COHORT TRACE STUDY
Ameen, A, Serra-Baldrich, E, Arm-Strong, A, Festini, T, Vinther, F, Vittrup, I, Wiseman, MC. EFFECTIVENESS OF 12-MONTHS TRALOKINUMAB TREATMENT IN 124 ADULTS WITH ATOPIC DERMATITIS WITH GENITAL INVOLVEMENT: FINAL REAL-WORLD DATA FROM THE PROSPECTIVE, NON-INTERVENTIONAL, INTERNATIONAL, SINGLE-COHORT TRACE STUDY. ACTA DERMATO-VENEREOLOGICA. 2025; 105DOI:. PMID:. IF:3.700(Q1/2D).
12/01/2024 Student survey after ten years of continuous blended teaching of echocardiography.
Parra VM, Fita G, Azqueta M, González M, Aranda F, Maestre M, Silva J, Hortal J, Morales D, Bórquez E, Adasme F, Real MI, Mercadal J, Zelada P, Riobó G, Galdames K, Domenech RJ. Student survey after ten years of continuous blended teaching of echocardiography.. Revista Espanola De Anestesiologia Y Reanimacion. 2024; 71(1)DOI:10.1016/j.redare.2023.05.004. PMID:37683971. IF:(Q/D).